Limited coverage criteria – glucagon

Last updated on March 18, 2025

 

Return to Special Authority drug list 

Generic name

glucagon

Strength & form

1 mg vial kit including sterile lyophilized powder in a single dose vial and diluent in a pre-filled syringe

Special Authority criteria

Approval period

For the treatment of severe hypoglycemia in patients for whom the nasal spray dosage form is not appropriate.

Indefinite

Practitioner exemptions

  • None

Special notes

  • This criteria applies to the US-labelled product imported through the Health Canada exceptional importation pathway

Special Authority request form(s)